TR200003453T2 - Yeni terkipler - Google Patents

Yeni terkipler

Info

Publication number
TR200003453T2
TR200003453T2 TR2000/03453T TR200003453T TR200003453T2 TR 200003453 T2 TR200003453 T2 TR 200003453T2 TR 2000/03453 T TR2000/03453 T TR 2000/03453T TR 200003453 T TR200003453 T TR 200003453T TR 200003453 T2 TR200003453 T2 TR 200003453T2
Authority
TR
Turkey
Prior art keywords
compositions
processes
preparation
new preparations
preparations
Prior art date
Application number
TR2000/03453T
Other languages
English (en)
Inventor
K. Johnson Randall
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22199389&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200003453(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of TR200003453T2 publication Critical patent/TR200003453T2/tr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/20Interleukins [IL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Bu bulus genel olarak, interferon-y-inducing factor (IGIF) olarak bilinen IL-18 gibi kuvvetlendiricileri, kemoterapötik madde ile kombinasyon halinde bulundugu terkipler ile, bu gibi terkiplerin hazirlanmasi için prosesler, bu gibi terkiplerin hazirlanmasi için prosesler, bu gibi terkiplerin kanserin önlenmesinde ve/veya tedavisinde kullanilmasi, bu gibi terkiplerin, memelilerde kanserli hücreler veya tümörlerin gelisimini önlemek için kullanilmasi ile ilgilidir.
TR2000/03453T 1998-05-21 1999-05-20 Yeni terkipler TR200003453T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8656098P 1998-05-21 1998-05-21

Publications (1)

Publication Number Publication Date
TR200003453T2 true TR200003453T2 (tr) 2001-10-22

Family

ID=22199389

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03453T TR200003453T2 (tr) 1998-05-21 1999-05-20 Yeni terkipler

Country Status (28)

Country Link
US (1) US6582689B1 (tr)
EP (1) EP1079818B1 (tr)
JP (1) JP4283998B2 (tr)
KR (1) KR100624588B1 (tr)
CN (1) CN1227027C (tr)
AR (1) AR019844A1 (tr)
AT (1) ATE245440T1 (tr)
AU (1) AU750918B2 (tr)
BR (1) BR9910622A (tr)
CA (1) CA2328603A1 (tr)
CO (1) CO5050337A1 (tr)
CZ (1) CZ300496B6 (tr)
DE (1) DE69909781T2 (tr)
DK (1) DK1079818T3 (tr)
ES (1) ES2204164T3 (tr)
GC (1) GC0000102A (tr)
HK (1) HK1035136A1 (tr)
HU (1) HUP0600520A2 (tr)
IL (2) IL139733A0 (tr)
MY (1) MY123434A (tr)
NO (1) NO329195B1 (tr)
NZ (1) NZ508115A (tr)
PL (1) PL200840B1 (tr)
PT (1) PT1079818E (tr)
TR (1) TR200003453T2 (tr)
TW (1) TWI227136B (tr)
WO (1) WO1999059565A1 (tr)
ZA (1) ZA200006675B (tr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60208692T2 (de) 2001-03-08 2006-07-13 Ares Trading S.A. Interleukin -18 mutantenproteine, deren herstellung und verwendung
US20050079153A1 (en) * 2002-08-14 2005-04-14 Pfizer Inc. Methods for enhancing immune functions in neonatal mammals by administration of IL-18
EP1572228A4 (en) * 2002-09-19 2009-03-04 Centocor Inc METHOD FOR INDUCING MATURATION OF DENDRITIC CELLS AND USES THEREOF
NZ552837A (en) * 2004-08-20 2009-09-25 Smithkline Beecham Corp Use of human IL-18 polypeptide for treating mucositis and diabetic ulcers
JP2010503680A (ja) * 2006-09-14 2010-02-04 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア ヒトil−18による調節t細胞のモジュレーション
PE20090190A1 (es) * 2007-03-23 2009-03-22 Smithkline Beecham Corp Combinacion de anticuerpos anti-cd20 y polipeptidos de il-18
GB0803352D0 (en) * 2008-02-22 2008-04-02 Ntnu Technology Transfer As Oligopeptidic compounds and uses thereof
US8168165B2 (en) * 2008-12-23 2012-05-01 Abbott Laboratories Alkylated interleukin-18 compositions
TW201506402A (zh) * 2013-08-15 2015-02-16 Tonyar Biotech Inc 自體防潮的檢驗芯片及其製造方法
CA3080492A1 (en) * 2017-09-06 2019-03-14 Yale University Interleukin-18 variants and methods of use
IL302517A (en) 2020-11-02 2023-07-01 Simcha Il 18 Inc Variants of interleukin-18 and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2697752B1 (fr) * 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Compositions antitumorales contenant des dérivés du taxane.
US6207641B1 (en) * 1995-03-10 2001-03-27 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Pharmaceutical composition containing IFN-γ inducing polypeptide or factor for treating and/or preventing IFN-γ susceptive diseases
JP4004088B2 (ja) * 1995-09-26 2007-11-07 株式会社林原生物化学研究所 免疫担当細胞においてインターフェロン−γの産生を誘導する蛋白質
TW464656B (en) * 1994-11-15 2001-11-21 Hayashibara Biochem Lab Interferon-gamma production inducing polypeptide monoclonal antibody, and agent for interferon-gamma susceptive disease
US5869535A (en) * 1995-03-21 1999-02-09 The Board Of Trustees Of The University Of Illinois Method and composition for selectively inhibiting melanoma
JP4024366B2 (ja) 1996-11-29 2007-12-19 株式会社林原生物化学研究所 ポリペプチド

Also Published As

Publication number Publication date
JP2003509333A (ja) 2003-03-11
PT1079818E (pt) 2004-02-27
CO5050337A1 (es) 2001-06-27
NO20005857D0 (no) 2000-11-20
CN1367686A (zh) 2002-09-04
NO329195B1 (no) 2010-09-13
ZA200006675B (en) 2002-02-27
AU750918B2 (en) 2002-08-01
DE69909781D1 (de) 2003-08-28
HUP0600520A2 (en) 2006-10-28
US6582689B1 (en) 2003-06-24
ES2204164T3 (es) 2004-04-16
EP1079818A4 (en) 2001-12-12
WO1999059565A1 (en) 1999-11-25
DK1079818T3 (da) 2004-04-19
AR019844A1 (es) 2002-03-20
CN1227027C (zh) 2005-11-16
NZ508115A (en) 2003-12-19
PL200840B1 (pl) 2009-02-27
CZ300496B6 (cs) 2009-06-03
IL139733A (en) 2009-06-15
DE69909781T2 (de) 2004-05-27
GC0000102A (en) 2005-06-29
HK1035136A1 (en) 2001-11-16
IL139733A0 (en) 2002-02-10
EP1079818B1 (en) 2003-07-23
CA2328603A1 (en) 1999-11-25
CZ20004321A3 (en) 2001-05-16
NO20005857L (no) 2000-11-21
EP1079818A1 (en) 2001-03-07
MY123434A (en) 2006-05-31
TWI227136B (en) 2005-02-01
PL366170A1 (en) 2005-01-24
KR20010052369A (ko) 2001-06-25
KR100624588B1 (ko) 2006-09-18
AU4309499A (en) 1999-12-06
ATE245440T1 (de) 2003-08-15
JP4283998B2 (ja) 2009-06-24
BR9910622A (pt) 2001-01-30

Similar Documents

Publication Publication Date Title
TR200101482T2 (tr) WT1'e özgü imünoterapi için bileşimler
TR200003453T2 (tr) Yeni terkipler
IL130669A0 (en) Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof
TR199901768T2 (tr) Bir kemoterapötik etken ile bir benzimidazolu ve istege bagli olarak bir potansiyatörü içeren, kanser gelisimini önlemeye yönelik kit.
TR200000151T2 (tr) Yeni bileşimler.
TR200003011T2 (tr) Yeni dihidropirimidinler.
DK0556310T3 (da) Quinazolinderivater til forhøjelse af antitumoraktivitet
NZ334034A (en) Use of a melanoma differentiation associated gene (mda-7) for reversing a cancerous phenotype
TR199900683T2 (tr) Sikline bagimli kinaz 2 ve IkB-alfa'nin pürin inhibitörleri.
WO2000028090A3 (en) Diagnostic assay for cancer
TR200000197T2 (tr) Yeni bileşimler
TR200003513T2 (tr) Pirolo[2,3d]Pirimidin kompozisyonları ve kullanımları
YU19499A (sh) Benzonaftiridini kao bronhijalni terapeutici
PL338339A1 (en) Novel derivatives of tetrazole
TR199800270T1 (tr) Kanser hastaliklarinin ilerlemesini önlemede flukonazol kullanimi.
CA2132001A1 (en) Methods of treating cancer using modified c-reactive protein
TR199800244T2 (tr) Griseofulvinin, kanserlerin ilerlemesini önlemede kullanimi.
MX9301083A (es) Complejos de quelato y procesos para su preparacion.
EP0163303A3 (en) Human monoclonal antibodies to cell surface and intracellular antigens
IT1298470B1 (it) Composti impiegati nella prevenzione del cancro della mammella e uso degli stessi
TR200101547T2 (tr) Askomisinleri içeren topik kompozisyonlar
DE69704833T2 (de) Derivate der thiazolidine-4-carbonsäure als cytoprotektive mittel
BR0108951A (pt) Uso de exemestano, e método para o tratamento de primeira linha de c ncer de mama
DE60043942D1 (de) Fluoreszierende cobalamine und deren verwendung
TR200002266T2 (tr) İnterlokin-6 üretimini canlandırıcı etkinliğe sahip bir bileşik içeren kozmetik kompozisyon.